日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine Inhibitor

特应性皮炎患者开始使用JAK抑制剂与Th2细胞因子抑制剂治疗时发生痤疮的风险比较

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2025.5443
Schneeweiss, Maria C; Wyss, Richard; Anand, Priyanka; Jin, Yinzhu; Mostaghimi, Arash; Barbieri, John S; Merola, Joseph F; Silverberg, Jonathan I; Rosmarin, David M; Glynn, Robert J; Schneeweiss, Sebastian
JAK/STAT
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Lebrikizumab Improves Clinical Manifestations, Symptoms, and Quality of Life in Patients with Moderate-to-Severe Atopic Dermatitis Previously Treated with Dupilumab: Results from the ADapt Study

利布利珠单抗可改善既往接受过度普利尤单抗治疗的中重度特应性皮炎患者的临床表现、症状和生活质量：ADapt 研究结果

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01644-3
Silverberg, Jonathan I; Ackerman, Lindsay; Bagel, Jerry; Stein Gold, Linda; Blauvelt, Andrew; Rosmarin, David; Chovatiya, Raj; Zirwas, Matthew; Yosipovitch, Gil; Waibel, Jill; Murase, Jenny E; Lockshin, Ben; Weisman, Jamie; Atwater, Amber Reck; Proper, Jennifer; Silk, Maria; Pierce, Evangeline; Piruzeli, Maria Lucia Buziqui; Montmayeur, Sonia; Schuster, Christopher; Zhong, Jinglin; Rueda, Maria Jose; Pillai, Sreekumar; Simpson, Eric
发表日期：2026
文献求助 收藏

Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort study

特应性皮炎免疫调节剂的使用情况及其预测因素：一项队列研究

期刊:
影响因子:
doi:10.1016/j.jdin.2025.10.016
Anand, Priyanka; Mostaghimi, Arash; Glynn, Robert; Jin, Yinzhu; Merola, Joseph F; Silverberg, Jonathan I; Rosmarin, David M; Sidbury, Robert; Landon, Joan; Schneeweiss, Maria C
免疫/内分泌
发表日期：2026
文献求助 收藏

Corrigendum to "Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study" [eClinicalMedicine 73(2024) 102655]

对“每日一次的upadacitinib与安慰剂治疗广泛性非节段型白癜风成人患者：一项2期、多中心、随机、双盲、安慰剂对照、剂量范围研究”的更正[eClinicalMedicine 73(2024) 102655]

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103167
Passeron, Thierry; Ezzedine, Khaled; Hamzavi, Lltefat; van Geel, Nanja; Schlosser, Bethanee J; Wu, Xiaoqiang; Huang, Xiaohong; Soliman, Ahmed M; Rosmarin, David; Harris, John E; Camp, Heidi S; Pandya, Amit G
发表日期：2025
文献求助 收藏

Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks

Upadacitinib治疗中重度特应性皮炎患者的疗效和安全性：3期随机临床试验140周结果

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00975-3
Irvine, Alan D; Prajapati, Vimal H; Guttman-Yassky, Emma; Simpson, Eric L; Papp, Kim A; Blauvelt, Andrew; Chu, Chia-Yu; Hong, H Chih-Ho; Gold, Linda F Stein; de Bruin-Weller, Marjolein; Bieber, Thomas; Kabashima, Kenji; Rosmarin, David; Sancho, Cristina; Calimlim, Brian M; Grada, Ayman; Yang, Yang; Wu, Xiaoqiang; Levy, Gweneth; Raymundo, Eliza M; Teixeira, Henrique D; Silverberg, Jonathan I
发表日期：2025
文献求助 收藏

Incidence of nonmelanoma skin cancer in patients with vitiligo who applied ruxolitinib cream

使用鲁索替尼乳膏治疗的白癜风患者发生非黑色素瘤皮肤癌的概率

期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.20379
Ezzedine, Khaled; Wolkerstorfer, Albert; Wei, Shaoceng; Korba, Abdelhak Amara; Kornacki, Deanna; Rosmarin, David
黑色素瘤
肿瘤
肿瘤免疫
皮肤癌
发表日期：2025
文献求助 收藏

Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks

使用鲁索替尼乳膏治疗白癜风患者 52 周后，各身体部位的色素再生情况

期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.20236
Passeron, Thierry; Harris, John E; Pandya, Amit G; Seneschal, Julien; Grimes, Pearl; Kornacki, Deanna; Wang, Mingyue; Ezzedine, Khaled; Rosmarin, David
发表日期：2025
文献求助 收藏

A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring System

评估近期上市的特应性皮炎系统治疗药物在临床实践中安全性的可扩展方法：序贯监测系统的第一分析周期

期刊:Journal of Investigative Dermatology
影响因子:5.7
doi:10.1016/j.jid.2024.08.034
Schneeweiss, Maria C; Glynn, Robert J; Wyss, Richard; Anand, Priyanka; Jin, Yinzhu; Landon, Joan; Mostaghimi, Arash; Merola, Joseph F; Silverberg, Jonathan I; Rosmarin, David M; Sidbury, Robert; Schneeweiss, Sebastian
发表日期：2025
文献求助 收藏

Prevalence and Association of Autoimmune Comorbidities Among Adults with Vitiligo: A Systematic Literature Review and Meta-analysis of USA-Based Studies

美国成人白癜风患者自身免疫性合并症的患病率及关联性：一项系统文献综述和荟萃分析

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01506-y
Liu, Jinan; Matangi, Sudheer; Malempati, Yogitha; Nasir, Adnan; Rosmarin, David
免疫/内分泌
发表日期：2025
文献求助 收藏

Long-Term Integrated Safety Summary of Ruxolitinib Cream in Phase 3 Clinical Trials of Patients with Vitiligo

鲁索替尼乳膏治疗白癜风患者3期临床试验的长期综合安全性总结

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01555-3
Rosmarin, David; Pandya, Amit G; Passeron, Thierry; Forman, Seth B; Zdybski, Jacek; Amster, Mark; Feser, Christina; Papp, Kim A; Nuara, Anthony; Kornacki, Deanna; Wei, Shaoceng; Ren, Haobo; Harris, John E; Ezzedine, Khaled
发表日期：2025
文献求助 收藏